MetaCap

Adagene Statistics

NASDAQ: ADAGHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.76-0.25 (-12.44%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Adagene by the numbers

Adagene has a market capitalization of $118.2 million based on 67.14M shares outstanding. With trailing EPS of $-0.37, Adagene is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 31.0% below its 50-day average and 48.1% below its 200-day average.

Average daily trading volume is 348.81K shares, or about $613,914 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ADAG valuation vs. peer median

ADAG compared with the median of 8 peer companies
MetricADAGPeer medianDifference
Market cap$118.17M$111.11M+6%
Avg. volume348.81K212.56K+64%

Peer median across 8 companies: MSLE, OKUR, MGNX, IMUX, MENS, SPRB, BGM, SION.

Valuation

Market cap
$118.17M
Price / sales (latest FY)
15.41
EPS (TTM)
$-0.37

Price and trading

Previous close
2.01
Open
2.00
Day range
1.35 – 2.05
52-week range
1.27 – 4.85
52-week change
-2.22%
Beta
—
Volume
1.37M

Dividends and events

Annual dividend
None
Next earnings date
Jul 23, 2025

Additional statistics

Market Cap
118.17M
Forward Pe
-3.14
Eps
-0.37
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
4.85
Week52 Low
1.27
Avg Volume
348.81K
Shares Outstanding
67.14M
Ma50
2.55
Ma200
3.39
Earnings Date
Jul 23, 2025
Pct From52w High
-63.71%
Pct From52w Low
38.91%

Related